SEARCH FIRM NEWS
On November 12, 2025, President Trump signed legislation into law that, effective November 13, 2026, severely restricts the level of THCs and THCA permitted in final form hemp products and essentially bans THC/THCA in such products. The scope of products affected includes products containing cannabinoids in any form and intended for human or animal use […]
Amin Wasserman Gurnani is proud to announce that it has been named to Best Lawyers – “Best Law Firms.”
Interest in GLP-1 products has grown exponentially over the past year. With this growth has come questions and scrutiny around the types of claims that can be made for dietary supplements intended for GLP-1 support — and rightly so, as there are boundaries regarding what can be said about the benefits of these products, and […]
NutraIngredients USA turned to Rend Al-Mondhiry for commentary on the increasing demand for nutritional support by surgical patients looking to speed up their recovery. Read the full story here.
The Best Lawyers in America has recognized Amin Wasserman Gurnani attorneys in its 2026 edition, lauding their work in multiple practice areas.
Cosmetics Design turned to Jennifer Adams for comment on an NAD decision highlighting the growing scrutiny of influencer marketing practices and the limitations of platform-based disclosure tools. Click here to read the full story.
NutraIngredients USA turned to Ivan Wasserman for comment on warning letters sent by the FTC to companies claiming their products are ‘Made in the USA’. The letters explained how the agency’s requirements apply to online marketplaces.
On July 14, 2025, FDA issued a Warning Letter to WHOOP, Inc. concerning its Blood Pressure Insights (BPI) feature, which the company had positioned as a non-regulated general wellness product. FDA asserted it was an unapproved medical device that required 510(k) clearance. This action could represent a significant shift in FDA’s enforcement priorities, which could […]
Interest in GLP-1 products has grown exponentially over the past year. With this growth has come questions and scrutiny around the types of claims that can be made for dietary supplements intended for GLP-1 support MORE >
see all news >